Atlas Trials

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

Clinical trial NCT06856226 · RECRUITING

Trial details

NCT number
NCT06856226
Sponsor
National Cancer Institute (NCI)
Status
RECRUITING
Study type
OBSERVATIONAL
LeukemiaLymphomaHematologic Malignancy
Start date
2026-03-04
Primary completion
2027-12-01
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.